Prognostic factors for wilms tumor recurrence: A review of the literature

Publication date

2021-07-01

Authors

Groenendijk, Alissa
Spreafico, Filippo
de Krijger, RonaldORCID 0000-0001-6871-1296ISNI 0000000393710847
Drost, Jarno
Brok, Jesper
Perotti, Daniela
van Tinteren, Harm
Venkatramani, Rajkumar
Godziński, Jan
Rübe, Christian

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

In high-income countries, the overall survival of children with Wilms tumors (WT) is ~90%. However, overall, 15% of patients experience tumor recurrence. The adverse prognostic factors currently used for risk stratification (advanced stage, high risk histology, and combined loss of heterozygosity at 1p and 16q in chemotherapy-naïve WTs) are present in only one third of these cases, and the significance of these factors is prone to change with advancing knowledge and improved treatment regimens. Therefore, we present a comprehensive, updated overview of the pub-lished prognostic variables for WT recurrence, ranging from patient-, tumor-and treatment-related characteristics to geographic and socioeconomic factors. Improved first-line treatment regimens based on clinicopathological characteristics and advancing knowledge on copy number variations unveil the importance of further investigating the significance of biological markers for WT recurrence in international collaborations.

Keywords

Pediatric, Prognosis, Recurrence, Wilms tumor, Oncology, Cancer Research

Citation

Groenendijk, A, Spreafico, F, de Krijger, R R, Drost, J, Brok, J, Perotti, D, van Tinteren, H, Venkatramani, R, Godziński, J, Rübe, C, Geller, J I, Graf, N, van den Heuvel-Eibrink, M M & Mavinkurve-Groothuis, A M C 2021, 'Prognostic factors for wilms tumor recurrence : A review of the literature', Cancers, vol. 13, no. 13, 3142, pp. 1-25. https://doi.org/10.3390/cancers13133142